Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson, provides medicines for an array of health concerns in several therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health.

from http://www.janssenpharmaceuticalsinc.com/our-company

Research Grants 106 show all


$75.6M
2015

$96M
2016

$116.4M
2017

$197.8M
2018

$142.4M
2019

Publications 28 show all

  • 2
    Piperazines/pharmacology
  • 2
    Piperidines/analysis
  • 2
    Piperidines/pharmacokinetics
  • 1
    Adenosine Deaminase/pharmacology
  • 1
    Adenosine/pharmacology
  • 1
    Anticonvulsants/pharmacology
  • 1
    Antifungal Agents/pharmacology
  • 1
    Bile/analysis
  • 1
    Candida/drug effects
  • 1
    Cell Movement

Patents 24,735show all

  • 8,308
    C07D - Heterocyclic compounds
  • 3,835
    A61K - Preparations for medical, dental, or toilet purposes
  • 846
    C07C - Acyclic or carbocyclic compounds
  • 563
    A01N - Preservation of bodies of humans or animals or plants or parts thereof
  • 419
    C07K - Peptides
  • 399
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 381
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 310
    Y02P - Climate change mitigation technologies in the production or processing of goods
  • 244
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 198
    C12N - Microorganisms or enzymes

Clinical Trials 394show all

114Phase 385Phase 263Phase 140N/A30Phase 425Other

Contact Information

Hopewell Township, NJ
United States